Kintor Pharma Announces the Approval for Phase II Clinical T

Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China

Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Suzhou , Jiangsu , Kintor Pharma , Prnewswire Kintor Pharmaceutical Limited Pharma , National Medical Products Administration , Kintor Pharmaceutical , Pharmaceutical Limited , Endeavor Biomedicines , Idiopathic Pulmonary Fibrosis , Evidence Based Guidelines ,